Introduction to HIV and patient outcomes - Masterclass 1 By Joshua Bryning What is HIV/AIDS?Human Immunodeficiency Virus (HIV) is a retrovirus that attacks a person’s immune system, in turn affecting their ability to fight off infections and diseases. More...
Oncology & Precision Medicine Conference: Alderley Park 10th – 11th December 2024 Join Us for the two-day Oncology & Precision Medicine Conference: explore the current oncology landscape on day one and the future of precision medicine on day two. Exhibiting on Day...
Unblinded Medical Review (UMR): How does it work in Pharmora? By Joshua Bryning During a sponsor-blinded study the majority of the study team are blinded and do not have access to much of the clinical trial information, but the patient and investigator know which...
Unblinded Medical Review (UMR): what is it and when is it needed? By Dr Stephanie-Jayne Jones Pharmora has many times been called upon to help with data review near the end of Phase III clinical trials, when the global study team find there is too much to do and their...
How can Pharmora help to commercialise your product? (Part 1) By Dr Stephanie-Jayne Jones Why do you need Pharmora? Medicines development background When a manufacturer discovers a new medicinal product there is a long process of development before it reaches patients...
